These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11345676)

  • 1. Harm reduction in the health care system: the legality of prescribing and dispensing syringes to drug users.
    Burris S; Lurie P; Ng M
    Health Matrix Clevel; 2001; 11(1):5-64. PubMed ID: 11345676
    [No Abstract]   [Full Text] [Related]  

  • 2. The genesis of syringe prescription to prevent HIV in Rhode Island.
    Rich JD; McKenzie M; Macalino G; Runnarsdottir V; Gaydos M; Mehrotra M; Stein J; Whitlock T; Salas C; Burris S
    Health Matrix Clevel; 2001; 11(1):129-45. PubMed ID: 11345673
    [No Abstract]   [Full Text] [Related]  

  • 3. An analysis of ethical issues in prescribing and dispensing syringes to injection drug users.
    Lazzarini Z
    Health Matrix Clevel; 2001; 11(1):85-128. PubMed ID: 11345679
    [No Abstract]   [Full Text] [Related]  

  • 4. Federal law and syringe prescription and dispensing.
    Abrahamson D
    Health Matrix Clevel; 2001; 11(1):65-71. PubMed ID: 11345677
    [No Abstract]   [Full Text] [Related]  

  • 5. The epidemics of injecting drug use and blood-borne disease: a public health perspective.
    Gostin LO
    Spec Law Dig Health Care Law; 1998 Jun; (231):9-40. PubMed ID: 10181048
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of HIV/AIDS and other blood-borne diseases among injection drug users. A national survey on the regulation of syringes and needles.
    Gostin LO; Lazzarini Z; Jones TS; Flaherty K
    JAMA; 1997 Jan; 277(1):53-62. PubMed ID: 8980211
    [No Abstract]   [Full Text] [Related]  

  • 7. Syringe access for the prevention of blood borne infections among injection drug users.
    Stancliff S; Agins B; Rich JD; Burris S
    BMC Public Health; 2003 Nov; 3():37. PubMed ID: 14633286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug use and harm reduction policy: alternative perspectives on the California proposal.
    Stauffer L
    J Health Soc Policy; 2004; 19(3):19-36. PubMed ID: 15829451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deregulation of syringes and needles for medical use and to prevent the spread of blood-borne pathogens among illicit injection drug users.
    Morse LJ
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S143-4. PubMed ID: 9663640
    [No Abstract]   [Full Text] [Related]  

  • 10. Should pharmacists sell sterile syringes to injection drug users?
    Jones TS; Taussig J
    J Am Pharm Assoc (Wash); 1999; 39(1):8-10. PubMed ID: 9990178
    [No Abstract]   [Full Text] [Related]  

  • 11. Why New Jersey needs to change its syringe access laws.
    Roberts JJ
    N J Med; 2004 Nov; 101(11):35-6. PubMed ID: 15605798
    [No Abstract]   [Full Text] [Related]  

  • 12. Prescribing syringes to injection drug users: what the family physician should know.
    Rich JD; Taylor L; Mehrotra M; Mason R; Stozek M; Stancliff S
    Am Fam Physician; 2003 Jul; 68(1):45-7. PubMed ID: 12887113
    [No Abstract]   [Full Text] [Related]  

  • 13. New York City pharmacists' attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access.
    Coffin PO; Linas BP; Factor SH; Vlahov D
    J Urban Health; 2000 Dec; 77(4):781-93. PubMed ID: 11194317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Making the case for harm reduction programs for injection drug users.
    Kulikowski J; Linder E
    Nursing; 2018 Jun; 48(6):46-51. PubMed ID: 29794629
    [No Abstract]   [Full Text] [Related]  

  • 15. A syringe prescription program to prevent infectious disease and improve health of injection drug users.
    Rich JD; McKenzie M; Macalino GE; Taylor LE; Sanford-Colby S; Wolf F; McNamara S; Mehrotra M; Stein MD
    J Urban Health; 2004 Mar; 81(1):122-34. PubMed ID: 15047791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In New York City, syringe laws and regulations deter physicians and pharmacists from prescribing and selling syringes to persons who may be injection drug users.
    Lazzarini Z; Schoenbaum EE; O'Neill CH
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S141-3. PubMed ID: 9663639
    [No Abstract]   [Full Text] [Related]  

  • 17. The impact of syringe deregulation on sources of syringes for injection drug users: preliminary findings.
    Deren S; Cleland CM; Fuller C; Kang SY; Des Jarlais DC; Vlahov D
    AIDS Behav; 2006 Nov; 10(6):717-21. PubMed ID: 16642418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syringe prescription for injection drug users to prevent disease.
    J Assoc Nurses AIDS Care; 2012; 23(3):275-6. PubMed ID: 22645745
    [No Abstract]   [Full Text] [Related]  

  • 19. Guidelines for better harm reduction: evaluating implementation of best practice recommendations for needle and syringe programs (NSPs).
    Strike C; Watson TM; Lavigne P; Hopkins S; Shore R; Young D; Leonard L; Millson P
    Int J Drug Policy; 2011 Jan; 22(1):34-40. PubMed ID: 20413288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syringe access for injection drug users in Rhode Island.
    Boutwell A; Rich JD
    Med Health R I; 2004 Jan; 87(1):15-6. PubMed ID: 14989076
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.